Clinical Trial Update: Astaxanthin for Management of Inflammation in Knee Osteoarthritis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating astaxanthin for inflammation in knee osteoarthritis was terminated, with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of the Knee

Drugs mentioned

• Astaxanthin

Snippet

Sponsor: Prisma Health-Midlands | Conditions: Osteoarthritis, Knee, Osteoarthritis Knees Both | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-05-20